Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$768M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$625M |
| 3 |
AGN
Allergan plc
AGN
|
+$427M |
| 4 |
McKesson
MCK
|
+$427M |
| 5 |
Johnson Controls International
JCI
|
+$427M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Uber
UBER
|
+$503M |
| 2 |
RTX Corp
RTX
|
+$457M |
| 3 |
Global Payments
GPN
|
+$441M |
| 4 |
Amazon
AMZN
|
+$388M |
| 5 |
Johnson & Johnson
JNJ
|
+$355M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.18% |
| 2 | Healthcare | 4.07% |
| 3 | Financials | 2.86% |
| 4 | Industrials | 2.85% |
| 5 | Consumer Discretionary | 2.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4026
Xtrackers MSCI Japan Hedged Equity ETF
DBJP
$723M
| $1.91M | ﹤0.01% |
53,913
-8,387
| -13% | -$334K |
|
4027
TherapeuticsMD
TXMD
$24M
| $1.91M | ﹤0.01% |
36,060
+30,279
| +524% | +$3M |
|
4028
Direxion Daily FTSE China Bear 3X ETF
YANG
$99.1M
| $1.91M | ﹤0.01% |
2,105
-1,348
| -39% | -$1.23M |
|
4029
PUT
Novavax
NVAX
$1.33B
| $1.91M | ﹤0.01% |
140,500
+101,600
| +261% | +$860K |
|
4030
PUT
Ionis Pharmaceuticals
IONS
$9.51B
| $1.91M | ﹤0.01% |
40,300
-30,900
| -43% | -$1.72M |
|
4031
NOV
NOV
$7.54B
| $1.91M | ﹤0.01% |
193,786
-1,146,061
| -86% | -$21.6M |
|
4032
Blackbaud
BLKB
$2.05B
| $1.9M | ﹤0.01% |
34,269
+6,752
| +25% | +$478K |
|
4033
CALL
10x Genomics
TXG
$7.31B
| $1.9M | ﹤0.01% |
30,500
+15,600
| +105% | +$1.22M |
|
|
4034
PUT
Direxion Daily FTSE China Bear 3X ETF
YANG
$99.1M
| $1.9M | ﹤0.01% |
2,095
+1,270
| +154% | +$1.15M |
|
|
JOYY
4035
JOYY Inc
JOYY
$3.68B
| $1.9M | ﹤0.01% |
+35,678
| New | +$2.07M |
|
|
NVRO
4036
CALL
DELISTED
NEVRO CORP.
NVRO
| $1.9M | ﹤0.01% |
19,000
-21,900
| -54% | -$2.63M |
|
|
FLXN
4037
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $1.9M | ﹤0.01% |
241,244
-27,085
| -10% | -$408K |
|
|
TWOU
4038
PUT
DELISTED
2U Inc
TWOU
| $1.9M | ﹤0.01% |
2,980
-613
| -17% | -$414K |
|
4039
iShares MSCI Intl Value Factor ETF
IVLU
$4.55B
| $1.9M | ﹤0.01% |
107,737
-81,146
| -43% | -$1.76M |
|
4040
MillerKnoll
MLKN
$1.62B
| $1.9M | ﹤0.01% |
85,400
-71,221
| -45% | -$2.46M |
|
4041
PUT
MasTec
MTZ
$23.9B
| $1.89M | ﹤0.01% |
57,800
+30,000
| +108% | +$1.53M |
|
4042
Neogen
NEOG
$2.54B
| $1.89M | ﹤0.01% |
56,464
+26,228
| +87% | +$861K |
|
4043
Dorman Products
DORM
$4.05B
| $1.89M | ﹤0.01% |
34,219
-7,832
| -19% | -$533K |
|
|
LADR
4044
Ladder Capital
LADR
$1.27B
| $1.89M | ﹤0.01% |
398,865
+266,675
| +202% | +$4.05M |
|
4045
CALL
iShares MSCI ACWI ETF
ACWI
$33.6B
| $1.89M | ﹤0.01% |
30,200
+21,000
| +228% | +$1.56M |
|
4046
Direxion Daily FTSE China Bull 3X ETF
YINN
$653M
| $1.89M | ﹤0.01% |
8,145
+5,426
| +200% | +$1.9M |
|
4047
PUT
AerCap
AER
$24B
| $1.89M | ﹤0.01% |
82,900
-40,400
| -33% | -$1.99M |
|
4048
CALL
Western Alliance Bancorporation
WAL
$8.98B
| $1.89M | ﹤0.01% |
61,700
+5,800
| +10% | +$277K |
|
4049
CALL
Carlyle Group
CG
$17.6B
| $1.89M | ﹤0.01% |
87,200
+44,300
| +103% | +$1.28M |
|
|
BCPC
4050
Balchem Corp
BCPC
$5.69B
| $1.89M | ﹤0.01% |
19,129
+11,924
| +165% | +$1.22M |
|
Similar funds
Ken Griffin's Q1 2020 Portfolio in Review
As of Q1 2020, Ken Griffin held 10,687 positions worth $222B, down 3.5% from $230B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin deployed $36.9B of net new capital in Q1 2020, opening 1,649 new positions and adding to 4,224 existing holdings. Its largest new stake was Invesco QQQ Trust: 2,950,335 shares worth $562M.
By sector, the portfolio is most concentrated in Technology at 4.2% of assets, down from 5.3% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Uber, an estimated $503M trimmed.
- Ken Griffin's largest Q1 2020 buy was Invesco QQQ Trust: 2,950,335 shares worth $562M.
- Ken Griffin added most to Charter Communications in Q1 2020, an estimated $768M increase.
- Ken Griffin's biggest Q1 2020 reduction was Uber, cutting an estimated $503M.
- Ken Griffin fully exited Zayo Group Holdings, Inc. in Q1 2020, selling an estimated $280M.
- Ken Griffin's ten largest holdings make up 32% of its $222B portfolio in Q1 2020.
- Ken Griffin opened 1,649 new positions and closed 1,165 in Q1 2020.
- Ken Griffin's portfolio value fell 3.5% quarter-over-quarter to $222B.
Based on Citadel Advisors's 13F filing for Q1 2020, filed 15 May 2020.